首页> 美国卫生研究院文献>Respirology Case Reports >Novel hybrid cryo‐radial method: an emerging alternative to CT‐guided biopsy in suspected lung cancer. A prospective case series and description of technique
【2h】

Novel hybrid cryo‐radial method: an emerging alternative to CT‐guided biopsy in suspected lung cancer. A prospective case series and description of technique

机译:新型混合冷冻放射方法:可疑肺癌中CT引导活检的新兴替代方法。预期案例系列和技术描述

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

In diagnosing peripheral pulmonary lesions (PPL), radial endobronchial ultrasound (R‐EBUS) is emerging as a safer method in comparison to CT‐guided biopsy. Despite the better safety profile, the yield of R‐EBUS remains lower (73%) than CT‐guided biopsy (90%) due to the smaller size of samples. We adopted a hybrid method by adding cryobiopsy via the R‐EBUS Guide Sheath (GS) to produce larger, non‐crushed samples to improve diagnostic capability and enhance molecular testing. We report six prospective patients who underwent this procedure in our institution. R‐EBUS samples were obtained via conventional sampling methods (needle aspiration, forceps biopsy, and cytology brush), followed by a cryobiopsy. An endobronchial blocker was placed near the planned area of biopsy in advance and inflated post‐biopsy to minimize the risk of bleeding in all patients. A chest X‐ray was performed 1 h post‐procedure. All the PPLs were visualized with R‐EBUS. The mean diameter of cryobiopsy samples was twice the size of forceps biopsy samples. In four patients, cryobiopsy samples were superior in size and the number of malignant cells per high power filed and was the preferred sample selected for mutation analysis and molecular testing. There was no pneumothorax or significant bleeding to report. Cryobiopsy samples were consistently larger and were the preferred samples for molecular testing, with an increase in the diagnostic yield and reduction in the need for repeat procedures, without hindering the marked safety profile of R‐EBUS. Using an endobronchial blocker improves the safety of this procedure.
机译:与CT引导下的活检相比,放射状支气管内超声(R‐EBUS)在诊断周围性肺部病变(PPL)方面正在出现。尽管安全性更好,但由于样本量较小,R‐EBUS的产量仍比CT引导的活检(90%)低(73%)。我们采用了一种混合方法,即通过R‐EBUS导引鞘(GS)进行冰冻活检,以生产更大的非压碎样品,从而提高诊断能力并增强分子测试。我们报告了六名在我们机构中接受此手术的准患者。 R-EBUS样品是通过常规采样方法(针吸,钳活检和细胞学刷检)获得的,然后进行了冷冻活检。事先在计划的活检区域附近放置了支气管内阻滞剂,并在活检后将其充气以使所有患者的出血风险降至最低。术后1小时进行胸部X光检查。所有PPL都通过R‐EBUS可视化。冷冻活检样本的平均直径是镊子活检样本大小的两倍。在四名患者中,冷冻活检样本的大小和每个高倍镜检出的恶性细胞数量均优越,是选择用于突变分析和分子测试的首选样本。没有气胸或大出血的报告。低温活检样品始终较大,并且是分子检测的首选样品,在不影响R‐EBUS显着安全性的情况下,提高了诊断率并减少了重复操作的需要。使用支气管内阻滞剂可提高该过程的安全性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号